Akebia Therapeutics to Report Third Quarter Financial Results and Highlight Recent Company Milestones
Akebia to Host Conference Call to Provide Business Update
Oct. 27, 2022
Akebia Therapeutics, Inc.
(Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the third quarter ended
September 30, 2022
Thursday, November 3, 2022
following the close of financial markets.
Akebia will host a conference call on
Thursday, November 3
4:30 p.m. ET
to discuss its financial results and recent company highlights. To access the call by phone via a new process, please click on this
and you will be provided with dial in details. To avoid delays, we encourage dialing into the conference call fifteen minutes ahead of the scheduled start time.
A live webcast of the conference call will be available via the Investors section of Akebia’s website at:
. An online archive of the webcast can be accessed via the Investors section of Akebia’s website at
About Akebia Therapeutics
Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease.
was founded in 2007 and is headquartered in
. For more information, please visit our website at
, which does not form a part of this release.
Akebia Therapeutics Contact
View original content to download multimedia:
SOURCE Akebia Therapeutics
Featured image: © healthhjm